UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 13, 2007
SIRTRIS PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware | | 001-33465 | | 20-1410189 |
(State or other jurisdiction of
of incorporation or organization) | | (Commission
File Number) | | (I.R.S. Employer
Identification No.) |
| | | | |
790 Memorial Drive, Cambridge, Massachusetts 02139 |
(Address of Principal Executive Offices) (Zip Code) |
Registrant’s telephone number, including area code: (617) 252-6920
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On August 13, 2007, Sirtris Pharmaceuticals, Inc. issued a press release relating to its results of operations and financial conditions for the quarter ended June 30, 2007. A copy of the press release is furnished as Exhibit 99.1 to this form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release issued by Sirtris Pharmaceuticals, Inc. on August 13, 2007.
2
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SIRTRIS PHARMACEUTICALS, INC. |
| | |
Dated: August 13, 2007 | By: | /s/ Christoph Westphal |
| Name: | Christoph Westphal |
| Title: | President and Chief Executive Officer |
3
Index to Exhibits
Exhibit No. | | Description | |
99.1 | | Press Release issued by Sirtris Pharmaceuticals, Inc. on August 13, 2007. | |
4
